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Does prior psychotherapy experience affect the course of
cognitive-behavioural group therapy for social anxiety disorder?
Abstract
OBJECTIVE: To examine whether and how different patterns of psychotherapy history (no prior
therapy, successful therapy experience, and unsuccessful therapy experience) affect the outcome of
future treatment among patients undergoing cognitive-behavioural group therapy for social anxiety
disorder. METHOD: Fifty-seven patients with varying histories of psychotherapy participating in
cognitive-behavioural group treatment for social anxiety disorder were included in the study. Symptom
severity (including anxiety, depression, self-efficacy, and global symptom severity) was assessed at pre-
and posttreatment. A therapist-rated measure of patient therapy engagement was included as a process
variable. RESULTS: First-time therapy patients showed more favourable pretreatment variables and
achieved greater benefit from group therapy. Among patients with unsuccessful therapy experience,
substantial gains were attained by those who were able to actively engage in the therapy process.
Patients rating previous therapies as successful could benefit the least and tended to stagnate. Possible
explanations for group differences and clinical implications are discussed. CONCLUSIONS: Prior
psychotherapy experience affects the course of cognitive-behavioural group therapy in patients with
social phobias. While patients with negative therapy experience may need extensive support in being
and remaining actively engaged, those rating previous therapies as successful should be assessed very
carefully and may benefit from a major focus on relational aspects.
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Objective: To examine whether and how different patterns of psychotherapy 
history (no prior therapy, successful therapy experience, unsuccessful therapy 
experience) affect outcome of future treatment among patients undergoing 
cognitive-behavioural group therapy for social anxiety disorder. 
Method: Fifty-seven patients with varying histories of psychotherapy 
participating in cognitive-behavioural group treatment for social anxiety disorder 
were included in the study. Symptom severity (including anxiety, depression, self-
efficacy and global symptom severity) was assessed at pre- and post-treatment. A 
therapist-rated measure of patient therapy engagement was included as a process 
variable. 
Results: First-time therapy patients showed more favourable pre-treatment 
variables and achieved greater benefit from group therapy. Among patients with 
unsuccessful therapy experience, substantial gains were attained by those who 
were able to actively engage in the therapy process. Patients rating previous 
therapies as successful could benefit the least and tended to stagnate. Possible 
explanations for group differences and clinical implications are discussed. 
Conclusions: Prior psychotherapy experience affects the course of cognitive-
behavioural group therapy in social phobic patients. While patients with negative 
therapy experience may need extensive support in being and remaining actively 
engaged, those rating previous therapies as successful should be assessed very 
carefully and may benefit from a major focus on relational aspects.  
  3 
Clinical implications 
• Differentiating between patients with successful and unsuccessful 
psychotherapy histories can be of crucial importance for clinicians 
• Patients with prior unsuccessful therapy experience can achieve satisfying 
gains but need to be supported in their efforts to actively engage in therapy 
• Not only unsuccessful therapies, but also successful treatments in the past 
should be discussed before starting a new psychotherapy. In particular, 
clinicians should explore the reasons why patients rate prior therapies as 
successful, why they seek a new treatment and what they expect from future 
therapy.  
 
Limitations 
• The study sample did not include patients deciding not to start a new therapy  
• The findings on patients rating prior therapies as successful may be 
accentuated in the study sample (social anxiety disorder) compared to the rest 
of psychiatric patients 
• Generalization to other diagnostic groups, therapeutic orientations and 
therapy settings needs to be confirmed by future studies.  
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An important portion of psychotherapy patients has a prior history of inpatient or 
outpatient treatment. Substance abusers for instance often undertake more than 
one treatment attempt. Among patients suffering from eating disorders, repeated 
psychotherapy experiences are more often a rule than an exception1. 
Psychotherapy history, together with a diagnosis of obsessive-compulsive 
disorder, predicted high-intensive use of mental health services among anxious 
patients2. Comorbidity and concomitant personality disorders are known as 
factors related to more extensive histories of psychiatric treatment3.  
Furthermore, previous psychotherapy experience can affect attitudes towards 
future treatments.. In a sample of depressed elderly patients, the degree of 
satisfaction with prior psychotherapy was associated with current preference for 
psychotherapy over pharmacological treatment4. Among anxiety disorders 
patients, those with psychotherapy history in the past 5 years rated 
pharmacological treatment (but not psychotherapy) as more credible compared to 
patients without recent psychotherapy history5. Similarly, a positive effect of 
treatment history was found among parents of anxious children in regards to 
medication treatment but not in regards to cognitive-behavioural therapy6.  
Empirical data available up to date does not allow for a firm conclusion on 
whether and how prior psychotherapy experience affects the course of future 
treatments. In a sample of 148 female sexual abuse survivors undergoing group 
therapy, those with previous psychotherapy experience achieved greater pre-post-
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treatment changes on the SCL-907. Similar findings are reported for long-term 
group therapy, where dropouts were more likely to have no previous experience 
of psychotherapy and more often had an axis II diagnosis than treatment 
completers8. A recent study on several thousand patients receiving behavioural 
health treatment did not however confirm prior outpatient treatment history as a 
factor influencing outcome6. Among anxiety disorders patients treated with 
cognitive-behavioural therapy, equivalent short- and long-term improvement was 
observed for those with or without therapy history in the last 5 years5.  
One possible explanation for the inconsistency of research literature on this matter 
is that, rather than prior psychotherapy itself,  the degree of satisfaction with prior 
psychotherapy attempts may have a differential impact on the course of future 
treatments. One study provided positive results in this direction: substance abuse 
patients with successful treatment histories showed improved cocaine abstention 
after a 14-weeks cognitive-behavioural therapy program and marginally better 
attendance than patients with negative psychotherapy experiences9. Based on 
these findings, it might be worth differentiating between patients perceiving prior 
therapy as helpful and those rating it as unhelpful. A comparison of these two 
groups with the group of patients seeking treatment for the first time may lead to 
more consistent results in regards to whether the variable “therapy experience” 
affects the benefit of future treatments.  
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Moreover, the inclusion of process variables highlighting possible mechanisms 
through which patient with different experiences may achieve more or less 
favourable outcomes has been neglected in past studies. Findings on whether and 
how such variables predict psychotherapy outcome would have strong 
implications for clinical practice as they could assist therapists in detecting 
patients with less favourable pre-treatment conditions. This would allow the 
planning of additional interventions such as specific pre-treatment trainings. 
The main purpose of the present study was to examine the patterns of past 
psychotherapy experience in a sample of patients with social anxiety disorder and 
to analyze how this variable affects the course of cognitive-behavioural group 
therapy. Patients with previous history of psychiatric treatment (especially a 
negative one) were expected to have more severe initial symptomatology than 
first-time therapy patients. The second hypothesis was that patients with negative 
psychotherapy experiences in the past would reach poorer outcomes compared to 
patients who rated previous treatments as effective and to those without 
psychotherapy experience. Finally, the differential effect of prior psychotherapy 
history on actual outcome as a function of the process variable therapy 
engagement was explored.
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Method 
 
Sample 
Study subjects were 57 consecutive outpatients (49% women) undergoing 
cognitive-behavioural group treatment for social anxiety disorder. All participants 
met DSM-IV criteria for social phobia and had Liebowitz Social Anxiety Scale 
(LSAS) intake scores within the social phobia range (M = 69, SD 26, 10). The 
average age was 35 years (SD 11). A minority of patients (n = 11, 19%) had no 
previous psychotherapy experience; 61% (n = 28) of those who had been in 
therapy before rated previous treatment as helpful and 49% (n= 18) as not helpful. 
About half of the patients (n = 29, 51%) sought group therapy on own initiative ; 
21 patients (37%) were referred by an external psychotherapist and the rest was 
referred by a primary care physician (N = 5, 9%) or by a family member (n = 2, 
3%). 
Eight patients (14%) terminated group therapy prematurely after a mean of 2.1 
sessions (SD 1.5). Post-treatment assessments were completed by 47 patients. In 
terms of pre-treatment variables, no significant differences were found between 
patients with missing data and those who completed all the assessments.  
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Intervention 
Treatment consisted of 10 sessions of cognitive-behavioural group therapy for 
social anxiety disorder over a 3-month period (the first five sessions weekly, 
sessions 6 to 10 on alternating weeks). Sessions lasted 90 minutes and there were 
6 to 8 participants in each group.  
The multimodal manualized treatment was based on the approaches of Hope, 
Heimberg and Stravynski11,12 as well as on the evaluation of previous group 
therapies13,14 and is routinely held at our Anxiety Disorders Unit. The main 
components of the group treatment included 1) applying the cognitive-behavioural 
model for social anxiety disorder to typical situations experienced by the patients; 
2) graded in-session exposures to feared social interactions (e.g. role playing of 
real situations, video feedback, shifting attention outward) as well as 
individualized exposures in real life and in vivo exposures in town; 3) addressing 
misconceptions of social situations and, based on new experiences, cognitive 
restructuring by identifying and challenging dysfunctional schemas (e.g. 
unrelenting standards or abandonment schemas); 4) developing personal strategies 
and identifying resources; 5) planning of realistic goals for the time after therapy; 
6) relapse prevention.  
Group therapy was delivered by three cognitive-behavioural therapists (two 
clinical psychologists and one psychiatrist), all of whom had extensive prior 
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experience with group therapy for anxiety disorders. Each group was led by two 
of the three therapists. 
 
Measures 
Prior psychotherapy experience. Patients were asked to answer the following two 
questions with yes or no: “Have you been in psychotherapy before?”; “If yes, was 
psychotherapy helpful to you?”.  
Anxiety. The self-rating version of the Liebowitz Social Anxiety Scale (LSAS)10 
was administered for assessing social anxiety and avoidance in typical social 
situations. The total score ranges from 0 to 144. General anxiety levels were 
measured with the Beck Anxiety Inventory BAI15. 
Self-efficacy. The Generalized Self-Efficacy Scale16 was included as a global 
measure of patients’ belief that their actions are responsible for successful 
outcomes. The global score ranges from 10 to 40.  
Depression. Depressive symptomatology was measured with the Beck Depression 
Inventory BDI17. 
Global symptom severity. A short version of the Symptom-Checklist (SCL-K-9) 18 
was included as a measure of global symptom severity. The SCL-K-9 is a 9-item 
scale with good psychometric properties showing a high correlation (r = .93) with 
the GSI-90. The global score ranges from 0 to 4.  
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Process variable “therapy engagement”. Patient engagement was assessed by the 
therapists on the two-item, seven-point Likert scale “effort” (range: -3 to +3) of 
the Bernese post-session Report (Regli D., Grawe K. The Bernese post-session 
report, a process and quality measure instrument). With the “effort” scale 
therapists are asked to rate patient engagement a) during the session und b) 
between the sessions (through the planning and evaluating of homework tasks 
therapists get quite a lot of information on how intensively and engaged each 
patient worked on his goals in real life). The internal consistency of the therapy 
engagement scale was Cronbach’s alpha = 0.89. Interrater reliability, based on 34 
ratings provided by two of the therapists, was calculated with two-way mixed 
models for random people effects and fixed target effects. The intraclass 
correlation coefficients (ICC, consistency type) was ICC = .84 (95%-CI range = 
.62 to .94) at the fifth session and ICC = .78 (95%-CI = .50 to .91) at post-
treatment.  
 
Procedure 
Patient eligibility for group therapy and for the study was evaluated by the 
therapists during two intake sessions. Besides confirming the diagnosis of social 
anxiety disorder (clinical interview according to DSM-IV criteria for social 
phobia and LSAS), assessing axis I and II comorbidity and evaluating the 
indication and motivation for group treatment, three specific therapy goals were 
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defined with each patient. The study was approved by the institutional review 
board (Zurich/Switzerland, Psychiatry board) and all participants provided written 
informed consent. 
Patients and therapists completed the assessment measures during the intake and 
after session 10 (post-treatment). Patient engagement (effort) was rated at session 
5 and 10, the individual mean score of the two assessment points was used for 
analyses. 
 
Statistical analyses 
Group comparisons were examined with t-tests, univariate analyses of variance 
and X2 tests. In order to test the contribution of pre-treatment variables 
(comorbidity, self-referral, medication) on therapy outcome, each outcome 
measure was regressed on each pre-treatment variable. Based on these findings, 
the effect of pre-treatment variables was then controlled in later analyses where 
necessary. General linear models for repeated measures were used to compare 
outcome between groups (no psychotherapy experience, prior successful therapy, 
prior unsuccessful therapy). Since the main focus of this study was to compare 
therapy progress between groups, only group x time interaction effects are 
reported in the results section.  
The predictive ability of the process variable “therapy engagement” on outcome 
was first explored with a series of regression analyses using a residualized 
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outcome score as the dependent variable. In order to be able to perform analyses 
with the whole sample, therapy history was recoded in two dummy variables 
(success and no success), where patients without therapy history served as the 
reference group. In the regression analyses, after controlling for the baseline 
score, therapy history (success and no success) and therapy engagement were 
entered separately or together.  
The impact of therapy engagement in relation to the five outcome measures was 
then tested in an additional set of hierarchical regression analyses for each group 
(no therapy experience, prior successful therapy, prior unsuccessful therapy) and 
for the whole sample as well. To control for patient’s pre-treatment level of 
distress, the initial score on each outcome measure being tested was entered in 
step 1 of the analyses (together with baseline depression levels where necessary). 
The process variable “therapy engagement” was then added in the second step. 
All significance tests were 2-tailed. Data were analyzed with SPSS 12.0.1 for 
Windows. 
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Results 
 
Pre-treatment variables 
A global comparison between patients with and without psychotherapy history 
showed that the first group was more depressed (BDI: M = 19.0, SD 10.3 vs. M = 
11.7, SD 3.8; t = -3.87, df = 54; P < 0.001) and more often prescribed 
psychotropic medication (58% vs. 25%; X2 = 4.07, df = 1, P < 0.05). On some 
measures, a general trend towards more severe baseline symptoms was found 
among patients with prior therapy experience (especially when this was rated as 
unsuccessful) and is shown in Table 1. However, differences between the three 
groups did not reach statistical significance on any of the symptom measures.  
Significant group differences were found with respect to comorbidity, where 
psychotherapy history was more often associated with the presence of comorbid 
diagnoses. Also, self-referral rates were higher among patients seeking therapy for 
the first time and lowest among patients with unsuccessful psychotherapy history. 
Possible effects of pre-treatment variables on outcome were tested by regressing 
each outcome measure on each pre-treatment variable. After controlling for pre-
treatment scores, the variables comorbidity, axis II comorbidity, self-referral and 
medication were not found to be associated with any of the outcome measures. 
The only exception was found for baseline depression scores, which predicted 
post-treatment LSAS (R2 change =  0.05; F change = 4.7, P < 0.05), SCL-K-9 (R2 
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change =  0.09; F change = 9.5, P < 0.01) and SE scores (R2 change =  0.12; F 
change = 9.9, P < 0.01). 
 
Dropouts 
Dropouts were evenly distributed among the three groups (X2 = 0.23, df = 2, P > 
0.05), showing that therapy history did not differentiate dropouts from completers.  
 
Post-treatment outcome 
Univariate analyses of variance revealed significant group x time effects for 
anxiety (BAI: F[2, 44] = 3.89, P < 0.05, η2 = 0.15) and depression (BDI: F[2, 44] 
= 3.80, P < 0.05, η2 = 0.15). After controlling for initial depression levels, group x 
time effects were also confirmed for global symptom severity (SCL-K-9: F[2, 43] 
= 4.18, P < 0.05, η2 = 0.16). As shown in Figure 1, patients with prior history of 
successful psychotherapy tended to improve the least (stagnation), while patients 
with negative psychotherapy experience were able to achieve substantial benefits. 
No significant group x time effects were found for the dependent variables social 
anxiety (LSAS) and self-efficacy (SE). 
 
Outcome predictors 
Further analyses were carried out to test the predictive ability of pre-treatment 
symptom severity, therapy history and the process variable “therapy engagement”. 
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A first series of regression analyses was performed with the whole sample by 
using a residualized post-treatment outcome score for the dependent variable. 
After controlling for the baseline score, therapy history (dummy variables success 
and no success) and therapy engagement were entered separately or together in 
the analyses. Results confirmed the predictive value of. psychotherapy history (R2 
change = .09 , F change[2, 41] = 6.5, P < 0.01), therapy engagement (R2 change = 
.07 , F change[1, 42] = 9.1, P < 0.01) and. of the combination of the two. (R2 
change = .13 , F change[3, 40] = 7.0, P < 0.01). 
Separate regression analyses for each outcome measure indicated that pre-
treatment scores were all strong outcome predictors of post-treatment outcome in 
the whole sample (Table 2). Interestingly, this relationship was found to reach 
significance among patients with previous (especially positive) therapy 
experience, while post-treatment symptom level among first-time therapy patients 
was not associated with initial symptom severity.  
Patient therapy engagement (“effort”) significantly increased outcome prediction 
in the whole sample and among patients with unsuccessful psychotherapy history, 
explaining additionally for up to 37% (BDI) of the outcome variance in this 
subgroup. 
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Discussion 
The main goal of this study was to examine how psychotherapy history affects 
short-term cognitive-behavioural group treatment and to explore whether patients 
with different psychotherapy experiences show different patterns in regards to 
how they benefit from group therapy.  
The findings presented in the previous section, based on a sample of patients 
undergoing group cognitive-behavioural therapy for social anxiety disorder, 
support the main hypothesis that experience and satisfaction with previous 
psychotherapy influence the course of future treatment.  
With lower baseline depression scores, less comorbidity and scarce use of 
psychotropic medication, patients seeking treatment for the first time in their life 
showed more favourable pre-treatment conditions than patients with repeated 
psychotherapy experiences. Furthermore, lower self-referral rates were observed 
among patients who rated prior therapy as unsuccessful compared to those with 
positive psychotherapy experience and to new patients. However, after controlling 
for pre-treatment confounding variables, patients with successful therapy history 
(and not those with unsuccessful therapy experience) were shown to be the ones 
achieving less favourable outcomes. 
Pre-treatment symptom severity was confirmed to be a strong outcome predictor 
for patients with previous treatment history and especially for those with positive 
experience but not for patients seeking therapy for the first time. Therefore, more 
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severely symptomatic patients with successful psychotherapy history seem to be 
particularly at risk not to benefit from group therapy. 
At a process level in addition to pre-treatment symptom severity, patient effort put 
into therapy was shown to predict outcome only in patients with unsuccessful 
therapy histories (Table 2): in this group, those who were able to actively work 
during and between sessions achieved the best results. 
In summary, first- time therapy patients were shown to benefit most from group 
therapy and to be the least vulnerable subgroup in terms of risk factors. Their 
therapy success was not influenced by pre-treatment symptom severity, maybe 
suggesting a more neutral attitude towards therapy and a greater ability in letting 
the therapy process work. It is also possible that through the lower comorbidity 
rates and depression level this group of patients had more resources to invest in 
group therapy. Although no group difference was found in terms of self-efficacy 
at baseline, patients without therapy history were more often self-referred. This 
could reflect a greater ability in attributing (even small) progress to one’s own 
efforts, which would promote a sense of mastery and facilitate change. 
As expected, patients with negative psychotherapy history had partially 
unfavourable starting conditions. However, results show that they could achieve 
substantial gains as long as they were able to actively engage and to remain 
engaged in the therapy process. This does not confirm the assumption that patients 
with negative psychotherapy experience in the past tend to benefit less from 
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future treatments. It is possible that these patients are disappointed from prior 
therapists and therefore feel more responsible for clinical improvement, but not all 
of them find a way of actively modify their situation. From a clinical point of 
view, the relevance of the process variable “therapy engagement” suggests that in 
this group of patients it might be particularly important to reinforce their 
initiative, to support possibilities to actively engage and to openly discuss reasons 
for not engaging.  
Surprisingly, patients with successful therapy history were the ones benefiting the 
least from group therapy. As shown in Figure 1 in the results section, these 
patients seemed to stagnate or to progress very slowly. In contrast to other 
patients, their outcome was mostly influenced by initial symptom severity, while 
the process variable “therapy engagement” did not significantly affect clinical 
improvement. It is possible that for some of these patients with positive prior 
experience the current therapy proved to be a relative disappointment, translating 
into poorer outcome. The unexpected findings concerning first-time therapy 
patients also raise the questions of how successful their prior therapies were in 
actuality, and whether the subjectivity of the success ratings constituted a bias. 
The hypothesis can be made that some of these patients might have been driven 
by loyalty feelings towards their prior therapist and did not want to question his or 
her ability or efficacy; maybe preferring to blame themselves instead of their 
therapist or the therapy process. Another possibility is that some subjects may 
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have provided a socially desirable response to show that they are “good” or 
“acceptable” patients” to the current therapist. It may be the case that such 
tendencies are particularly accentuated among patients with social anxiety 
disorder, characterized by the effort to please or at least not to disappoint others, 
by dependence from other people’s opinions and by impaired self-efficacy. By 
putting their efforts into impression management, some patients might have tried 
to keep their rejection anxiety at a tolerable level. This assumption is consistent 
with the lack of predictive power of concrete engagement for clinical 
improvement in the subgroup of patients with positive psychotherapy history, 
possibly reflecting a stronger need for a trustful therapeutic relationship rather 
than a need for mastery like in the group of patients with negative experiences. 
Additional process variables including therapeutic alliance may have been 
relevant for testing this interpretation and should be included in future studies on 
this topic.  
Some practical implications can be drawn from the findings concerning the 
particular group of patients rating previous therapies as successful. First, it seems 
particularly important for clinicians to carefully assess not only past therapy 
failures but also to explore the reasons why a patient with successful therapy 
history seeks a new treatment. It might be essential for these patients to get the 
possibility to openly talk about previous therapy processes and to discuss their 
attitudes and expectations towards future treatments or therapists. Second, 
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therapists should be particularly vigilant in regularly and critically checking with 
this group of patients on how they experience the therapy process.  
Some limitations of the present study should be considered as well. The main 
limitation is that our sample of patients with psychotherapy history does not 
represent all those who attempted therapy before. Since we have no information 
on those who chose not to try therapy again, our sample may differ from the 
entireness of patients with previous experience in terms of motivation, self-
efficacy and maybe better support through family or primary care physician in 
being encouraged for a new therapy attempt. A prospective study focusing on 
future utilization of psychotherapy among all patients with psychotherapy history 
could complement the results presented here. Further, it should be borne in mind 
that this study is based on a sample of social phobics undergoing cognitive-
behavioural group therapy. Future research should assess whether the presented 
findings can be generalized to other diagnostic groups and whether similar 
patterns can be confirmed for individual therapy. Finally, it might be worth 
improving the specificity of the central variable “previous therapy experience” in 
future studies. Assessing the kind of previous therapy (including details on 
orientation, setting and length) could provide further information on the 
differential impact of specific successful vs. unsuccessful therapy forms. 
Additionally, the inclusion of broader success ratings (e.g., based on 5- or 7-point 
scales) would allow analyses of the whole sample and result in increased power. 
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As a conclusion, the present study confirms that patients seeking therapy for the 
first time tend to benefit more from group therapy but also shows that it is 
essential to differentiate between the types of prior therapy experience. While 
patients with negative experiences seem to need special support in increasing their 
active therapy engagement, patients rating previous therapies as successful may 
need specific pre-treatment assessments and a more careful focus on the 
therapeutic relationship.  
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Figure 1  
 
Interaction between prior psychotherapy history and time with regard to 
symptom level 
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Table 1. 
Pre-treatment characteristics (n = 57)   
  Psychotherapy history    
  None  
(n = 11) 
Successful 
(n = 28) 
Unsuccessful 
(n = 18) 
   
  M   SD M  SD M  SD F (df = 56) P 
LSAS  61.3 13.4 70.2 20.8 77.7 20.3 2.30 ns 
BAI  16.8 4.9 18.0 10.1 21.8 11.3 1.18 ns 
BDI  12.2 3.4 18.5 11.7 19.1 8.3 2.08 ns 
SCL  1.4   .6 1.6 .8 1.9 .7 1.32 ns 
SE  20.9 2.0 22.2 4.9 21.8 4.4   .34 ns 
Age  28.6 7.6 34.9 10.5 38.3 13.0 2.65 (*)
  n % n % n % X2 (df=2) P 
Sex (females)  3 27% 16 57% 9 50% 2.83 ns 
Medication  3 27% 15 54% 11 61% 3.29 ns 
Comorbidity  2 18% 23 82% 15 83%    17.61 ***
   Axis I   1 9% 16 57% 6 33% 8.11 * 
   Axis II   1 9% 16 57% 12 66% 9.92 ** 
Self-referral  8 73% 16 57% 5 28% 6.38 * 
 
LSAS = Liebowitz Social Anxiety Scale; BAI = Beck Anxiety Inventory; BDI = 
Beck Depression Inventory; SCL = Symptom-Checklist (9-item version); SE = 
Schwarzer Self-Efficacy Scale. 
X2 = Pearson Chi Square 
(*) P < 0.10; * P < 0.05; ** P < 0.01; *** P < 0.001.  
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Table 2 Summary of hierarchical regression analyses for pre-treatment and 
process variables predicting post-treatment outcome 
 
  
 
Whole sample
No 
psychotherapy 
history 
Successful 
psychotherapy 
history 
Unsuccessful 
psychotherapy 
history 
 R2change Fchange R2change Fchange R2change Fchange R2change Fchange
LSAS 
Pre-treatment LSAS, BDIa 
Therapy engagement 
 
.56 
.07 
 
27.6***
  7.5* 
 
.29 
.29 
 
1.2 
3.5 
 
.45 
.03 
 
10.6** 
  1.2 
 
.70 
.106 
 
12.1** 
  2.2 
BAI 
Pre-treatment BAI 
Therapy engagement 
 
.47 
.15 
 
39.1***
16.7***
 
   <.01 
.14 
 
    <.1 
1.0 
 
.56 
.07 
 
27.7*** 
  4.1(*) 
 
.60 
.21 
 
17.9** 
12.2** 
BDI 
Pre-treatment BDI 
Therapy engagement 
 
.64 
.05 
 
80.1***
   7.1* 
 
.17 
.04 
 
1.5 
  .3 
 
.81 
.02 
 
92.0*** 
  2.0 
 
.27 
.37 
 
  4.5(*) 
11.2** 
SCL 
Pre-treatment SCL, BDIa 
Therapy engagement 
 
.58 
.07 
 
30.0***
  8.0** 
 
.23 
.18 
 
.92 
1.5 
 
.78 
.01 
 
38.2*** 
     .8 
 
.41 
.34 
 
   3.9(*) 
16.3** 
SE 
Pre-treatment SE, BDIa 
Therapy engagement 
 
.37 
.01 
 
20.9***
  1.1 
 
.07 
.16 
 
     .2 
1.1 
 
.70 
<.01 
 
23.1*** 
 <.1 
 
.38 
.19 
 
  3.4(*) 
  4.5(*) 
 
a To control for pre-treatment level of depression, initial BDI score was entered in 
step 1 of the analyses (together with the pre-treatment score on each outcome 
measure being tested) 
LSAS = Liebowitz Social Anxiety Scale; BAI=Beck Anxiety Inventory; BDI = 
Beck Depression Inventory; SCL = Symptom-Checklist (9-item version); SE = 
Schwarzer Self-Efficacy Scale. 
(*) P < 0.10; * P < 0.05; ** P < 0.01; *** P < 0.001.  
 
